Plasma‐based biomarkers for Aβ and tau predict longitudinal brain atrophy in cognitively healthy elderly and in patients with Alzheimer’s disease
Antoine Leuzy(Banner Sun Health Research Institute), Henrik Zetterberg(University of Wisconsin–Madison), Patrizia Mecocci(University of Perugia), Kaj Blennow(Sahlgrenska University Hospital), Niklas Mattsson(Malmö University), Oskar Hansson(Eli Lilly (United States)), Bruno Vellas(Centre Hospitalier Universitaire de Toulouse), Abdul Hye(King's College London), Iwona Kłoszewska(Medical University of Lodz), Dag Aarsland(King's College London), Thomas K. Karikari(University of Pittsburgh), Gustav Mårtensson(Karolinska Institutet), Magda Tsolaki(Aristotle University of Thessaloniki), Michael Schöll(Wallenberg Wood Science Center), Eric Westman(Wellcome Centre for Human Neuroimaging), Nicholas J. Ashton(King's College London), Simon Lovestone(Royal Buckinghamshire Hospital), Andréa Lessa Benedet(McGill University Health Centre), Joel Simrén(University of Gothenburg)
Cited by 0
Related Papers
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
Diagnosis and management of dementia with Lewy bodies
|Neurology|2017|4.4k
A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease
|Alzheimer s & Dementia|2014|3.1k